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Abstract
Background: Sexually transmitted infections (STIs) and Reproductive tract infections (RTIs) are responsible for high 
morbidity among women. We aim to quantify the magnitude of the burden and risk factors of STI/RTI s among 
pregnant women in Zimbabwe.
Methods: A cross sectional study of pregnant women enrolled at 36 weeks of gestation from the national PMTCT 
program. Study was conducted from three peri-urban clinics around Harare Zimbabwe offering maternal and child 
health services.
Results: A total of 691 pregnant women were enrolled. Prevalence of HSV was (51.1%), HIV (25.6%) syphilis (1.2%), 
Trichomonas vaginalis (11.8%), bacterial vaginosis (32.6%) and Candidiasis (39.9%). Seven percent of the women had 
genital warts, 3% had genital ulcers and 28% had an abnormal vaginal discharge. Prevalence of serological STIs and 
vaginal infections were 51% and 64% respectively.
Risk factors for a positive serologic STI were increasing age above 30 years, polygamy and multigravid; adjusted OR
(95% CI) 2.61(1.49-4.59), 2.16(1.06-4.39), 3.89(1.27-11.98) respectively, partner taking alcohol and number of lifetime
sexual partners. For vaginal infections it was age at sexual debut; OR (95% CI) 1.60(1.06-2.42). More than 25% of the
women reported previous STI treatment. Fifty two percent reported ever use of condoms and 65% were on oral
contraceptives. Mean age gap for sexual partners was 6.3 years older.
Conclusions: There is a high morbidity of STI/RTIs in this cohort. There is need to continuously screen, counsel, treat 
and monitor trends of STI/RTIs to assess if behaviour changes lead to reduction in infections and their sustainability.
Background
Sexually transmitted infections (STIs) and Reproductive
tract infections (RTIs) are responsible for considerable
morbidity in women of fertile age [1].
Zimbabwe is one of the countries in Sub Saharan Africa
that is hardest hit by HIV. The epidemic is now declining
due to associated behaviour change and a declining prev-
alence in STIs [2,3]. The high HIV prevalence is associ-
ated with histories of STI/RTIs and multiple sexual
partners [4-6]. Prevalence of syphilis has been reported to
range from 0.5 to 6.7%, HSV from 40 up to 67.1%,
Trichomonas vaginalis 9.9 to 21%, whilst gonorrhoea and
chlamydia range from 0.9% and 3.9% respectively [5-12].
Pregnant women are the most appropriate target group
for studying and identifying factors regarding sexual
behaviour and STI/RTIs as they present with evidence of
unprotected sex. Sexual behaviours are essential comple-
ments to biological evidence in understanding STI/HIV
epidemiology. Although there is a link between sexual
behaviour and the spread of STI/HIV, this has been
reported to be varied and complex [13-15].
It is the changes in behaviours that can be measured
which make it possible to elucidate and make conclusions
of changes in STI/HIV prevalence. This analysis needs to
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be updated periodically in order to determine the evi-
dence-based change and inform policy makers appropri-
ately. The aim of the present paper is to quantify the
magnitude of the burden of STI/RTIs and risk factors for
their acquisition among pregnant women enrolled under
a Prevention of Mother to Child Transmission (PMTCT)
program in Zimbabwe.
Methods
A cross sectional study of pregnant women enrolled at 36
weeks of gestation from three peri-urban clinics around
Harare Zimbabwe offering maternal and child health ser-
vices.
These women were recruited from the national
PMTCT program where they had been voluntarily coun-
seled and tested for HIV. Trained counselors and mid-
wives verbally invited the women into the study.
Midwives explained the study procedure and if the
w o m e n  a g r e e d  t o  p a r t i c i p a t e  t h e y  t h e n  s i g n e d  a n
informed consent form.
A study questionnaire was interview administered to
source information on socio demographic, lifestyle, sex-
ual and reproductive history, contraception and condom
use, current and past medical history and presenting gen-
ital infections symptoms.
A doctor or a midwife carried out a physical and
gynaecological examination including collection of a high
vaginal swab. Venous blood was drawn and for each pro-
cedure a verbal explanation was given. Women were
included in the study if they were 36 weeks pregnant or
more, had come through the national PMTCT program,
had been tested for HIV and intended to deliver their
i n d e x  b a b y  a t  a n y  o n e  o f  t h e  s t u d y  s i t e s .  T h e y  w e r e
excluded if they planned to deliver elsewhere or had a his-
tory of previous or presenting obstetric complication.
Laboratory methods
A complete blood count was performed using an auto-
mated cell counter. Serum creatinine and liver function
t e s ts  w e r e  ca rri ed  o u t.  T w o  H IV - r a p i d  t e s ts,  ( o r a q u i c k
and determine) were used to detect HIV seropositivity
and in the case of an indeterminant result; a Western blot
ELISA analysis was done. If any test was positive, a con-
firmatory HIV rapid test was done. Syphilis serology was
done using plasma reagin assay for screening and
Treponema pallidum hemagglutination assay for confir-
mation. Herpes simplex virus type-2 (HSV-2) antibodies
were measured by IgG-based type specific ELISA test
(POCkit™ HSV-2) Candidiasis was detected by direct
microscopy after addition of 10% KOH. Trichomonas
vaginalis was demonstrated by wet mount microscopy.
Bacterial vaginosis was diagnosed based on Amsells crite-
ria; positive whiff test; pH > 4.5 and detection of clue cells
or absence of lactobacilli on wet mount and by Gram
stain.
The STI/RTIs were grouped into two main categories:
1) STI positives (based on the serological tests; syphi-
lis, HSV-2 and HIV-1)
2) Vaginal infections comprising of (Trichomoniasis,
bacterial vaginosis and candidiasis).
Treatment for STI/RTIs
Women who presented or were diagnosed as suffering
from an STI were provided with treatment and given an
appointment to return after one week. They were also
given contact slips for their sexual partners encouraging
them to visit the study sites for treatment provided by the
study.
Ethical considerations
The local communities, the Medical Research Council of
Zimbabwe as well as the Norwegian ethical review com-
mittee approved the study.
Statistical analysis
Data was entered and analyzed using Chicago Illinois Sta-
tistical Package for Social Scientists (SPSS) version 12.0.
Level of significance was set at p value < 0.05. Unadjusted
odds ratios with their 95% confidence intervals were cal-
culated for risk factors of the STIs. Thereafter, risk factors
that were significant (p < 0.05) in univariate analysis were
entered in multiple logistic regression to calculate
adjusted odds ratios.
Results
A total of 691 pregnant women were recruited and
enrolled into the study between April 2002 and October
2003 and responded to the study questionnaire. Of those
women that were enrolled, 13(1.9%) did not have a bio-
logical sample collected at enrollment and were therefore
removed from this analysis.
Socio-demographic characteristics
Their mean age and standard deviation (s.d) was 24.2
(5.1) years, with the majority 568(82%) having attained at
least eight years of primary education, 648(94%) were
married and of these 104(10%) were in a polygamous
relationship. Only 20% of the women were earning some
f o r m  o f  i n c o m e  w h e r e a s  3 0 %  w e r e  f r e q u e n t  t r a v e l e r s .
Sixty seven percent of the women had their sexual debut
before attaining their 20th birthday. The women reported
a mean (s.d) pregnancy rate of 2.1(1.2) and parity 1.0(1.1)
respectively.
Current STI/RTIs
Baseline prevalence of HSV-2 was (51.1%), HIV (25.6%)
syphilis (1.2%), Trichomonas vaginalis (11.8%), bacterialKurewa et al. BMC Infectious Diseases 2010, 10:127
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vaginosis (32.6%) and candidiasis (39.9%) whilst 81.3. % of
the women had a vaginal pH > 4.5. On gynaecological
examination, (7%) of the women had genital warts whilst
(3%) had genital ulcers and (28%) had an abnormal vagi-
nal discharge. Fifty one percent of the women had a posi-
tive serological STI, whilst (64%) had one or more vaginal
infections.
Serological STIs increased with age with the highest
prevalence being among those above 30 years old OR
(95%CI) 3.04(1.78-5.19) compared to those below 20
years of age. Vaginal infections decreased with age, being
more prevalent among those below 20 years though not
statistically significant.
History of being treated for STI/RTIs
More than twenty five percent of the women reported
having been treated for an STI within the past twelve
months. History of having been treated for vaginal dis-
charge was 17.6%, genital ulcers 8.9% and genital warts
7.3%.
Condom and contraceptive use
More than half of the women (52%) reported ever use of
condoms whilst 65% were on oral contraceptives.
Sexual partners' characteristics
The mean age of sexual partners in this cohort was 6.3
years older than their women counterparts. Thirty three
percent of the women alluded to having more than one
lifetime sexual partner and less than 5% had more than
one partner in the preceding year.
Risk factors for a positive serological STI
Women above 30 years of age had a higher risk of testing
positive for serological STIs whilst they were also associ-
ated with being in a polygamous relationship and having
an income. Increasing age and polygamy remained strong
predictors even after adjusting for other demographic
characters. In the multivariate analysis of obstetric fac-
tors multigravid was the strong predictor for having a
positive serological STI. Adjusted and unadjusted odds
ratios and their 95% CI for demographic and obstetric
characteristics are demonstrated in Table 1.
Sexual partners of women who tested positive for a
serological STI were older compared to those of negative
ones, mean age 31.7 and 28.6 years respectively p < 0.001.
Sexual partners' characteristics were significantly asso-
ciated with a positive serological STI where in the multi-
variate model it is partner taking alcohol that remained as
significant predictor, OR (95%CI) 1.16(1.01-1.33).
Women who reported having more than one lifetime sex-
ual partner and having children with different paternity
were more likely to test positive for a serological STI even
after adjusting for other partner characteristics (Table 2).
Clinical features for those with a positive serological STI
Women presenting with genital warts and genital ulcers
o n  e x a m i n a t i o n  w e r e  m o r e  l i k e l y  t o  t es t  pos i t i v e  f o r  a
serological STI, whilst trichomonas vaginalis was the
strongest predictor of these infections; OR (95%CI)
3.10(1.71-5.64).
Risk factors for vaginal infections
Sexual debut before 20th birthday was the most significant
predictor for having a vaginal infection even after con-
trolling for other observed and reported symptoms, OR
(95% CI) 1.60(1.06-2.42) (Table 3).
Being in a polygamous relationship was significantly
associated with having trichomonas vaginalis; OR (95%
CI) 2.24(1.09-4.56). There was no significant association
between obstetric characteristics and vaginal infections.
Clinical features of vaginal infections
Women who presented with clinical warts on examina-
tion were more likely to have bacterial Vaginosis, OR
(95% CI); 2.86(1.45-5.62). Vaginal infections were associ-
ated with curd like vaginal discharge and yellow vaginal
discharge on examination.
Discussion
Reproductive tract infections and sexually transmitted
infections continue to cause considerable morbidity
among pregnant women. Prevalence of these infections
in this cohort is high with more than fifty percent of the
women presenting with either a positive serogical STI or
a vaginal infection. HSV-2 was the most prevalent STI,
whilst syphilis was the least prevalent.
HIV prevalence in this cohort is within the range of fig-
ures reported in the country at that time [3,18]. Syphilis is
a routinely screened infection in pregnancy and if the
women had booked for antenatal care in their first tri-
mester there are higher chances that they could have
been treated. The prevalence of HSV-2, T. vaginalis and
BV in our study is consistent with what has been reported
in the country, although most of the studies did not
report on pregnant populations [5,7,8,15-20]. Prevalence
of Candidiasis in this cohort is much higher compared to
the 25% reported by Mbizvo in 2001 [5].
High vaginal pH was the strongest predictor of having a
vaginal infection. It has been reported that women in
Zimbabwe practice vaginal douching, which to a large
extend disturb their normal vaginal flora predisposing
them to infections [21].
Different predictors were observed for serological STIs
and vaginal infections because the former are chronic in
nature whilst the latter are acute infections which can be
completely cured. Due to the cross sectional design of the
study we cannot establish which infection came first,
HIV, syphilis or HSV-2 [[8,9,17], and [22]].Kurewa et al. BMC Infectious Diseases 2010, 10:127
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Table 1: Demographic characteristics as risk factors for serologically tested STIs
Risk factors Serologic STI Positive Serologic STI
negative
Unadjusted odds
ratio (95% CI)
Adjusted odds ratio
(95% CI)
Age in years n = 320 n = 302
<20 50 (40) 74 (60) 1
20-24 100 (43) 130 (57) 1.14 (0.73-1.77) 1.09 (0.69-1.74)
25-29 96 (61) 62 (39) 2.29 (1.42-3.70) 2.10 (1.28-3.45)
30+ 74 (67) 36 (33) 3.04 (1.78-5.20) 2.61 (1.49-4.59)
Type of marriage n = 313 n = 285
Monogamy 277 (50) 272 (50) 1
Polygamy 36 (73) 13 (27) 2.71 (1.41-5.24) 2.16 (1.06-4.39)
Income generation n = 321 n = 299
No 262 (49) 268 (51) 1
Yes 59 (66) 31 (34) 1.95 (1.22-3.10) 1.60 (0.95-2.68)
Gravidae n = 322 n = 300
Prima-graviade 75 (34) 145 (66) 1
Multigravidae 247 (61) 155 (39) 3.08 (2.18-4.34) 3.89 (1.27-11.91)
Parity n = 322 n = 300
No children 86 (36) 151 (64) 1
More than one child 236 (61) 149 (39) 2.78 (1.96-3.94) 0.61 (0.20-1.91)
History of infant death n = 310 n = 298
No 274 (49) 281 (51) 1
Yes 36 (72) 14 (28) 2.63 (1.39-4.99) 1.24 (0.54-2.87)
History of stillbirths n = 320 n = 298
No 284 (50) 284 (50) 1
Yes 36 (72) 14 (28) 2.57 (1.36-4.87) 1.47 (0.64-3.39)
History of contraception n = 321 n = 299
No 87 (38) 142 (55) 1
Yes 234 (60) 157 (40) 2.43 (1.74-3.40) 0.94 (0.52-1.71)
Ever used condoms n = 314 n = 292
No 161 (48) 174 (52) 1
Yes 153 (56) 118 (44) 1.40 (1.02-1.93) 1.34 (0.92-1.93)
Serologically tested STIs positive was the outcome in multivariate analysisKurewa et al. BMC Infectious Diseases 2010, 10:127
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Association of increasing age with a positive serological
STI are because older women have been sexually active
for a longer period, thereby increasing their exposure to
infections. Polygamous relationships lead to sexual part-
ner mixing and infidelity, as the women's partners seek
other sexual partners or vice versa [19].
Those having an income could have been exposed to
infections by offering sexual favours in return for casual
work to earn some income. This study was conducted at
the time when levels of unemployment were quite high
compounded by high inflation in the country [2,23].
High morbidity of vaginal infections among young
women and their association with teenage sexual debut is
consistent with what has been reported; as their genital
tract are not fully developed, this exposes them to higher
risk of STI/RTIs acquisition [16,20]. Association of multi-
gravid and multiparity with testing positive for a serologi-
cal STI is due to longer periods of unprotected sex as
couples seek to conceive; this increases their risks of
infection.
History of stillbirths and infant deaths' association with
STI seropositivity is consistent with studies reporting
Table 2: Sexual partners' characteristics as risk factors for serological STIs
Risk factors Serologic STI Positive Serologic STI
negative
Unadjusted odds
ratio (95% CI)
Adjusted odds ratio
(95% CI)
Partner has penile 
discharge
n = 301 n = 286
No 288 (51) 282 (49) 1
Yes 13 (76) 4 (24) 3.18 (1.03-9.88) 2.74 (0.70-10.75)
Partner has genital 
ulcers
n = 301 n = 302
No 280 (50) 279 (50) 1
Yes 21 (78) 6 (22) 3.49 (1.39-8.77) 2.22 (0.82-6.0)
Partner takes alcohol n = 304 n = 287
No 122 (44) 156 (56) 1
Yes 182 (58) 131 (42) 1.78 (1.26-2.49) 1.16 (1.01-1.33)
Violent partner n = 310 n = 290
No 188 (48) 200 (52) 1
Yes 122 (58) 90 (42) 1.44 (1.02-2.02) 1.14 (0.78-1.65)
Number of lifetime 
sexual partners
n = 319 n = 300
One only 203 (45) 245 (55) 1
More than one 116 (68) 55 (32) 2.55 (1.76-3.69) 1.92 (1.21-3.06)
Children have different 
paternity
n = 305 n = 281
No 236 (48) 258 (52) 1
Yes 69 (75) 23 (25) 3.28 (1.98-5.43) 1.94 (1.04-3.62)
Sexual partners in the 
past year
n = 318 n = 300
One only 304 (51) 297 (49) 1
More than one 14 (82) 3 (18) 4.55 (1.29-16.02) 1.66 (0.41-6.73)
Serologically tested STIs positive was the outcome in multivariate analysisKurewa et al. BMC Infectious Diseases 2010, 10:127
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that maternal STIs have a direct impact on the outcome
o f  t h e  i n f a n ts  [ 1 1 ] .  U l c e r a t i v e  d is e as e s  i n cr e as e  ris k  o f
contracting HIV and other STIs thus Clinical genital
ulcers and warts were positive predictors for testing posi-
tive for a serological STI [10,11].
Seventy five percent of reported previous infections
predicted testing positive for a serological STI. Self
reporting of previous infections is quite high (25%) in this
cohort compared to what was reported in another study
where none of the women reported any previous infec-
tions [11]. Acknowledgement of one's previous infections
can be attributed to the positive impact of the counseling
that the women receive through PMTCT VCT.
Self-reporting of STI symptoms is a positive observa-
tion as it compels one to seek medical treatment early.
Seeking prompt treatment for STI symptoms will
increase women's chances of being counseled to take an
HIV test together with their sexual partners. Once
screened for HIV women will then seek to protect them-
selves from infection and re-infections for those testing
positive.
Contraceptive and condom use was quite high in our
study, above sixty percent compared to what has been
reported both in the Demographic Health Surveys (DHS)
and other studies [24].
The association between condom use and testing posi-
tive for a serological STI is due to the chronic nature of
the infections, where once infected one remains positive
throughout their life time. Positive behaviour change
after an HIV test has been reported in behavioral studies
where those testing positive are likely to use condoms
consistently. Use of condoms will in turn protect them
against vaginal infections.
Table 3: Gynaecologically examined risk factors for vaginal infections
Risk factors Vaginal Infections
Positive
Vaginal Infections
Negative
Unadjusted odds
ratio (95% CI)
Adjusted odds ratio
(95% CI)
Age debut n = 439 n = 237
>20 years 120 (57) 92 (43) 1
<20 years 319 (69) 145 (31) 1.69 (1.21-2.36) 1.60 (1.06-2.42)
Vaginal pH n = 353 n = 319
<4.5 56 (52) 51 (48) 1
>4.5 302 (65) 161 (35) 2.06 (1.35-3.15) 1.67 (1.04-2.68)
Curd-like vaginal 
discharge
n = 357 n = 202
Absent 198 (59) 135 (41) 1
Present 159 (70) 67 (30) 1.61 (1.13-2.32) 1.54 (1.00-2.38)
Yellow vaginal 
discharge
n = 339 n = 208
Absent 217 (58) 155 (42)
Present 122 (70) 53 (30) 1.64 (1.12-2.41) 1.71 (1.08-2.72)
Abnormal vaginal 
discharge
n = 434 n = 238
Absent 292 (60) 191 (40) 1
Present 142 (75) 47 (25) 1.98 (1.35-2.88) 1.59 (0.96-2.60)
Reported genital 
itchiness
n = 239 n = 434
No 251 (59) 174 (41) 1
Yes 183 (74) 65 (26) 1.95 (1.38-2.75) 1.29 (0.82-2.03)
Vaginal infections positive was the outcome in multivariate analysisKurewa et al. BMC Infectious Diseases 2010, 10:127
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Sexual partners' characteristics were strong predictors
for a positive serological STI reflecting on the role of sex-
ual partners in fueling these infections. The higher part-
ner age gap is because male partners are sexually active
for a longer period with multiple sexual partners which
exposes them to infections [[1,5], and [7]]. For a meaning-
ful impact to be achieved in preventing STI/RTI infec-
tions, interventions should target health education that
involves and promotes positive behavior changes among
males.
Women in this study had a considerably high STI/RTI
morbidity in pregnancy despite the reported positive
behaviour of increased condom use, and reduced number
of sexual partners in the preceding year. Two years after
PMTCT was initiated, reported positive behaviour
change is noted. Our data supports the observed declines
in HIV prevalence associated with behaviour changes
[3,18].
The strength of this study is that it was conducted at
the time when the epidemic had reached a mature stage;
characterized with declines in HIV prevalence and inci-
dence attributed to a reduction in STI/RTIs and positive
behaviour changes too.
Conclusion
In this cohort STI/RTIs morbidity is high and that risk
factors have remained the same. Positive behaviour is
reported in increased condom use and a reduction in
number of sexual partners. There is need to continuously
screen and monitor trends in STI/RTIs infections and
assess whether these behaviour changes are sustained
and consistent with reduction in STI/RTIs. Screening and
treating women for both serological STIs and vaginal
infections are of public health importance and should be
reinforced by timeous contact tracing of sexual partners
for those infected.
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